Additionally, DNASE1L3 impeded HCC progression by binding to beta-catenin thereby promoting its ubiquitination degradation and subsequently suppressing downstream signaling pathways involved in cell cycle and EMT (Li, et al., 2022). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.